BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1866064)

  • 1. Leukocyte-derived mediators and biocompatibility.
    Tetta C; Segoloni G; Mariano F; Montrucchio G; Turello E; Camussi G
    Nephrol Dial Transplant; 1991; 6 Suppl 2():24-30. PubMed ID: 1866064
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the biocompatibility of haemodialysis membranes.
    Schulman G; Hakim RM
    Nephrol Dial Transplant; 1991; 6 Suppl 2():10-3. PubMed ID: 1866056
    [No Abstract]   [Full Text] [Related]  

  • 3. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Criteria of the biocompatibility of the membranes used in dialysis].
    Stratta P; Canavese C; Segoloni GP; Dogliani M; Racca M; Coppo R; Vercellone A
    Minerva Nefrol; 1981; 28(2):109-11. PubMed ID: 6457263
    [No Abstract]   [Full Text] [Related]  

  • 6. Biocompatibility of dialysis membranes.
    Salem M; Ivanovich P; Mujais S
    Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063
    [No Abstract]   [Full Text] [Related]  

  • 7. Biocompatibility of various dialyzer membranes. The effects of the dialyzer membranes on the lymphocyte subpopulation during hemodialysis.
    Miyazawa S; Morita T; Osaki K; Uemura S; Nakashima A; Harada R; Otsuji Y; Hashimoto S
    Fukuoka Igaku Zasshi; 1986 Jul; 77(7):366-72. PubMed ID: 3770646
    [No Abstract]   [Full Text] [Related]  

  • 8. New aspects of biocompatibility of hemodialysis membranes.
    Wauters JP; Markert M
    Adv Nephrol Necker Hosp; 1991; 20():275-80. PubMed ID: 2063716
    [No Abstract]   [Full Text] [Related]  

  • 9. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
    ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatibility in hemodialysis. Workshop on biocompatibility in hemodialysis, Bernried, March 18-20, 1982.
    Contrib Nephrol; 1983; 36():1-138. PubMed ID: 6839764
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical relevance of biocompatibility in hemodialysis.
    Klinkmann H
    Verh K Acad Geneeskd Belg; 1987; 49(1):59-81. PubMed ID: 3604410
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to dialysis biocompatibility: evaluation through in vivo investigation of lymphocyte biology. A technical note.
    Stefoni S; Feliciangeli G; Nanni Costa A; Coli L; Cianciolo G; De Sanctis LB; Buscaroli A; Iannelli S; Mosconi G; Bonomini V
    Contrib Nephrol; 1993; 103():65-75. PubMed ID: 8354064
    [No Abstract]   [Full Text] [Related]  

  • 16. Section III. Biocompatibility.
    European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association
    Nephrol Dial Transplant; 2002; 17 Suppl 7():32-44. PubMed ID: 12386216
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the biocompatibility of haemodialysis membranes.
    Hakim RM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426
    [No Abstract]   [Full Text] [Related]  

  • 18. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-term evaluation of the biocompatibility of nine different haemodialysis membranes.
    Forêt M; Hachache T; Meftahi H; Milongo R; Kuentz F; Christollet M; Alibeu C; Cordonnier DJ
    Life Support Syst; 1987; 5(3):203-6. PubMed ID: 3695581
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
    Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.